The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 787-794

  Weyer, Christian ^a,b   Bogardus, Clifton ^a   Mott, David M ^a   Pratley, Richard E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY FAT; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0032742992     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7231     Document Type: Article

References (65)

1. Weir, G.C., and Leahy, J.L. 1994. Pathogensis of non-insulin-dependent (type II) diabetes mellitus. In Joslin's diabetes mellitus. 13th edition. C.R. Kahn and G.E. Weir, editors. Lea & Febiger. Philadelphia, PA. 240-264.
2. Bogardus, C. 1996. Metabolic abnormalities in the development of non-insulin-dependent diabetes mellitus. In Diabetes mellitus. D. LeRoith, S.I. Taylor, and J.M. Olefski, editors. Lippincot-Raven Publishers. Philadelphia, PA. 459 pp.
3. DeFronzo, R.A. 1988. Lilly Lecture 1987. The triumvirate: B-cell, muscle, liver. A collision responsible for NIDDM. Diabetes. 37:667-687.
4. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
5. World Health Organization. 1985. Diabetes mellitus: report of a WHO study group. World Health Organization Technical Report Series, Volume 17, 45 pp.
6. American Diabetes Association. 1998. Report of an expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 21(Suppl. 1):S5-S19.
7. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
8. DeFronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews. 5:177-269.
9. DeFronzo, R.A., Bonadonna, R.C., and Ferrannini, E. 1992. The pathogenesis of NIDDM. A balanced overview. Diabetes Care. 15:318-368.
10. Groop, L.C., Widen, E., and Ferrannini, E. 1993. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia. 36:1326-1331.
11. Taylor, S.I., Accili, D., and Imai, Y. 1994. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes. 43:735-740.
12. Ferrannini, E. 1998. Insulin resistance vs. insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 19:477-490.
13. Reaven, G.M., and Olefsky, J.M. 1977. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia. 13:201-206.
14. Reaven, G.M., Hollenbeck, C.B., and Chen, Y.D.I. 1989. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia. 32:52-55.
15. Bogardus, C., Lillioja, S., Howard, B.V., Reaven, G., and Mott, D.M. 1984. Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J. Clin. Invest. 74:1238-1246.
16. Cerasi, E., Luft, R., and Efendic, S. 1972. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes. 21:224-234.
17. Eriksson, J., et al. 1989. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N. Engl. J. Med. 321:337-343.
18. Pimenta, W., et al. 1996. Insulin secretion and insulin deficiency in people with impaired glucose tolerance. Diabet. Med. 13:S33-S36.
19. Yoneda, H., et al. 1992. Analysis of early-phase insulin responses in non-obese subjects with mild glucose intolerance. Diabetes Care. 15:1517-1521.
20. O'Rahilly, S.P., et al. 1986. Beta-cell dysfunction, rather than insulin in sensitivity, is the primary defect in familial type 2 diabetes. Lancet. 2:360-364.
21. Kosaka, K., Kuzuya, T., Hagura, R., and Yoshinaga, H. 1996. Insulin response to oral glucose load is consistently decreased in established non-insulin dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of diabetes mellitus. Diabet. Med. 13:S109-S119.
22. Pimenta, W., et al, 1995. Pancreeatic beta-cell dycfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA. 273:1855-1861.
23. Perseghin, G., Ghosh, S., Gerow, K., and Shulman, G.I. 1997. Metabolic defects in lean nondiabetic offspring of NIDDM parents. A cross-sectional study. Diabetes. 46:1001-1009.
24. Gulli, G., Ferrannini, E., Stern, M., Haffner, S., and DeFronzo, R.A. 1992. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 41:1575-1586.
25. Zimmet, P., Whitehouse, S., Alford, F., and Chisholm, D. 1978. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia. 15:23-27.
26. Haffner, S.M., Miettinen, H., Gaskill, S.P., and Stern, M.P. 1996. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia. 39:1201-1207.
27. Wilson, P.W., McGee, D.L., and Kannel, W.B. 1981. Obesity, very low density lipoproteins, and glucose intolerance over 14years. The Framingham study. Am. J. Epidemiol. 114:697-704.
28. Knowler, W.C., Pettitt, D.J., Saad, M.F., and Bennett, P.H. 1990. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab. Rev. 6:1-27.
29. Ohlson, L.D., et al. 1985. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 34:1055-1058.
30. Lillioja, S., et al. 1993. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329:1988-1992.
31. Martin, B.C., et al. 1992. Role of glucose and insulin resistance in development of type 2 diabetes. Results of a 25-year follow-up study. Lancet. 340:925-929.
32. Warram, J.H., Martin, B.C., Krolewski, A.S., Soeldner, J.S., and Kahn, C.R. 1990. Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Ann. Intern. Med. 113:909-915.
33. Saad, M.F., et al. 1991. A two-step model for development of non-insulin dependent diabetes mellitus. Am. J. Med. 90:229-235.
34. Charles, M.A., et al. 1991. Risk factors for NIDDM in white population: Paris prospective study. Diabetes. 40:796-799.
35. Chen, K.W., et al. 1995. Earlier appearance of impaired insulin secretion than of visceral adipocity in the pathogenesis of NIDDM. Diabetes Care. 18:747-753.
36. Nagi, D.K., et al. 1995. Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance. Diabetologia. 38:187-192.
37. Warram, J.H., Sigal, R.J., Martin, B.C., Krolewski, A.S., and Soeldner, J.S. 1996. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet. Med. 13:S40-S45.
38. Efendic, S., Luft, R., and Wajngot, A. 1984. Aspects of the pathogenesis of type 2 diabetes. Endocr. Rev. 5:395-410.
39. Lundgren, H., Bengtsson, C., Blohme, G., Lapidus, L., and Waldenstroem, J. 1990. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabet. Med. 7:407-413.
40. Kadowaki, T., et al. 1984. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 26:44-49.
41. Leahy, J.L. 1990. Natutal history of β-cell dysfunction in NIDDM. Diabetes Care. 13:992-1010.
42. Lillioja, S., and Bogardus, C. 1988. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab. Rev. 4:517-540.
43. Abbott, W.G.H., Howard, B.V., Ruoloto, G., and Ravussin, E. 1990. Energy expenditure in humans: effects of dietary fat and carbohydrate. Am. J. Physiol. 258:E347-E351.
44. Goldman, R.F., and Buskirk, E.R. 1961. A method for underwater weighing and the determination of body density. In Techniques for measuring body composition. J. Brozek and A. Herschel, editors. National Research Council. Washington, DC. 78-106.
45. Siri, W.E. 1961. Body composition from fluid spaces and density: analysis of methods. In Techniques for measuring body composition. J. Brozek and A. Herschel, editors. National Research Council. Washington, DC. 223-244.
46. Tataranni, P.A., Larson, D.E., and Ravussin, E. 1994. Body fat distribution and energy metabolism in obese men and women. J. Am. Coll. Nutr. 13:569-574.
47. Bogardus, C., et al. 1984. Relationship between obesity and maximal stimulated glucose uptake in vivo and in vitro in Pima Indians. J. Clin. Invest. 78:1568-1578.
48. Bogardus, C., Lillioja, S., and Ravussin, E. 1986. Familial dependence of the resting metabolic rate. N. Engl. J. Med. 315:96-100.
49. Gerich, J.E. 1998. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 19:491-503.
50. Schwartz, M.W., Boyko, E.J., Kahn, S.E., Ravussin, E., and Bogardus, C. 1995. Reduced insulin secretion: an independent predictor of body weight gain. J. Clin. Endocrinol. Metab. 80:1571-1576.
51. Bergman, R.N., Phillips, L.S., and Cobelli, C. 1981. Physiological evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68:1456-1467.
52. Bergman, R.N. 1989. Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes. 38:1512-1527.
53. Herbert, Y., Lau, K., Gottlieb, C.W., and Bleicher, S.J. 1965. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25:1375-1384.
54. Yalow, R.S., and Berson, S.A. 1960. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39:1157-1167.
55. SAS Institute Inc. 1990. SAS/STAT user's guide, version 6. 4th edition. SAS Institute Inc. Cary, NC. 1-44.
56. Mott, D., Pratley, R.E., and Bogardus, C. 1998. Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in non-diabetic Pima Indians are related to glycogen synthase fractional activity in cultured myoblasts. J. Clin. Invest. 101:2251-2256.
57. Kelley, D.E., Mokan, M., and Mandarino, L.J. 1992. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes. 41:698-706.
58. Shulman, G.I., et al. 1990. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13 C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322:223-228.
59. Lillioja, S., et al. 1988. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. 318:1217-1225.
60. Calles-Escandon, J., and Robbins, D.C. 1987. Loss of early phase insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes. 36:1167-1172.
61. Luzi, L., and DeFronzo, R.A. 1989. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am. J. Physiol. 257:E241-E246.
62. Bruce, D.G., Chisholm, D.J., Storlien, L.H., and Kraegen, E.W. 1988. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes. 37:736-744.
63. Brunzell, J.D., et al. 1976. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab. 42:222-229.
64. Unger, R. 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes. 44:863-870.
65. Paolisso, G., et al. 1998. Lowering fatty acids potentiates acute insulin response in first-degree relatives of people with type 2 diabetes. Diabetologia. 41:1127-1132.